Topics

LGC’s Clinical Diagnostics unit employing AccuPlex™ technology to develop quality control solutions in response to the coronavirus global health emergency

03:30 EST 13 Feb 2020 | Lab Bulletin

lgcs-clinical-diagnostics-unit-employing-accuplexLGC’s SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostic manufacturers and clinical laboratories, is announcing the development of molecular reference materials for coronavirus utilizing their proprietary AccuPlex™ recombinant technology. The control material is being produced in collaboration with several diagnostic manufacturers to support development, evaluation, and validation of molecular test methods directed to 2019-nCoV....

Original Article: LGC’s Clinical Diagnostics unit employing AccuPlex™ technology to develop quality control solutions in response to the coronavirus global health emergency

NEXT ARTICLE

More From BioPortfolio on "LGC’s Clinical Diagnostics unit employing AccuPlex™ technology to develop quality control solutions in response to the coronavirus global health emergency"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...